AAV-Delivered Tulp1 Supplementation Therapy Targeting Photoreceptors Provides Minimal Benefit in Tulp1−/− Retinas
MyNeuroNews,
With marketing approval of the first ocular gene therapy, and other gene therapies in clinical trial, treatments for inherited…